Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-05

Clinical Trial Update: Evaluating Simvastatin's Potential Role in Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating simvastatin for Alzheimer disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2015-11-05